PCM
GRCL

Pentwater Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Pentwater Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,461,000
Closed -$14.7M – 98
2023
Q4 		$14.7M Buy
+1,461,000
New +$14.7M 0.16% 33